CytoDyn Inc. Convertible Notes Payable
CytoDyn Inc. (CYDY) had Convertible Notes Payable of $38.34 million as of 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleNotesPayable · last filed 2026-08-31
- 2026-05-31: Convertible Notes Payable $38.34M.
- 2026-02-28: Convertible Notes Payable $40.53M.
- 2025-11-30: Convertible Notes Payable $42.17M.
- 2025-08-31: Convertible Notes Payable $43.78M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2026-05-31 | $38.34M 10-K · filed 2026-08-31 | |
| 2026-02-28 | $40.53M S-1 · filed 2026-04-22 | |
| 2025-11-30 | $42.17M 10-Q · filed 2026-01-09 | |
| 2025-08-31 | $43.78M 10-Q · filed 2025-10-10 | |
| 2025-05-31 | $45.35M 10-K · filed 2026-08-31 | |
| 2025-02-28 | $45.84M 10-Q · filed 2025-04-14 | |
| 2024-11-30 | $46.08M 10-Q · filed 2025-01-14 | |
| 2024-08-31 | $45.31M 10-Q · filed 2024-10-15 | |
| 2024-05-31 | $45.02M S-1 · filed 2026-04-22 | |
| 2024-02-29 | $44.25M 10-Q · filed 2024-04-15 | |
| 2023-11-30 | $45.85M 10-Q · filed 2024-01-16 | |
| 2023-08-31 | $44.87M 10-Q · filed 2023-10-23 | |
| 2023-05-31 | $45.73M 10-K · filed 2024-08-15 | |
| 2023-02-28 | $45.43M 10-Q · filed 2023-04-10 | |
| 2022-11-30 | $45.21M 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $43.95M 10-Q/A · filed 2022-10-13 | |
| 2022-05-31 | $42.22M 10-K · filed 2023-09-14 | |
| 2022-02-28 | $40.50M 10-Q · filed 2022-04-11 | |
| 2021-05-31 | $64.75M 10-K · filed 2022-08-15 | |
| 2020-07-27 | $9.50M 10-Q · filed 2021-01-08 | $9.54M 10-Q · filed 2020-10-09 |
| 2017-05-31 | $1.15M 10-K · filed 2017-07-20 | |
| 2015-05-31 | $50.00K 10-K · filed 2015-07-10 | |
| 2014-05-31 | $1.50M 10-K · filed 2015-07-10 | $4.27M 10-K · filed 2014-07-10 |
| 2014-02-28 | $4.52M 10-Q · filed 2014-04-11 | |
| 2012-11-30 | $257.30K 10-Q · filed 2013-01-14 |